BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1875465)

  • 1. [Combined CA-125 test and ultrasonography in the presurgical evaluation of ovarian mass].
    Chiu SW; Ho SC; Hung YC; Lee YH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Aug; 7(8):429-34. PubMed ID: 1875465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of ultrasonography and CA-125 test in the preoperative evaluation of ovarian carcinoma.
    Gadducci A; Capriello P; Bartolini T; Barale E; Cappelli N; Facchini V; Fioretti P
    Eur J Gynaecol Oncol; 1988; 9(5):373-6. PubMed ID: 3066622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective multicenter study on CA 125 in postmenopausal pelvic masses.
    Maggino T; Gadducci A; D'Addario V; Pecorelli S; Lissoni A; Stella M; Romagnolo C; Federghini M; Zucca S; Trio D
    Gynecol Oncol; 1994 Aug; 54(2):117-23. PubMed ID: 8063233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new sonomorphologic scoring-system (Mainz score) for the assessment of ovarian tumors using transvaginal ultrasonography. Part II: A comparison between the scoring-system and the assessment by an experienced sonographer in postmenopausal women.
    Weber G; Merz E; Bahlmann F; Leber AM
    Ultraschall Med; 1999 Feb; 20(1):2-8. PubMed ID: 10226339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical evaluation of transvaginal Doppler studies, transvaginal sonography, magnetic resonance imaging, and CA 125 in detecting ovarian cancer.
    Hata K; Hata T; Manabe A; Sugimura K; Kitao M
    Obstet Gynecol; 1992 Dec; 80(6):922-6. PubMed ID: 1448260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging.
    Weiner Z; Thaler I; Beck D; Rottem S; Deutsch M; Brandes JM
    Obstet Gynecol; 1992 Feb; 79(2):159-62. PubMed ID: 1731278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA 125 in the diagnosis of pelvic masses.
    Mogensen O; Mogensen B; Jakobsen A
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1187-90. PubMed ID: 2767108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of ovarian tumors by transvaginal color-pulse Doppler sonography.
    Kawai M; Kikkawa F; Ishikawa H; Tamakoshi K; Maeda O; Hasegawa N; Mizuno K; Suzuki A; Itakura A; Nakashima N
    Gynecol Oncol; 1994 Aug; 54(2):209-14. PubMed ID: 8063248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doppler sonography of adnexal masses: the predictive value of the pulsatility index in benign and malignant disease.
    Salem S; White LM; Lai J
    AJR Am J Roentgenol; 1994 Nov; 163(5):1147-50. PubMed ID: 7976891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonographic accuracy in the diagnosis of ovarian masses.
    Benacerraf BR; Finkler NJ; Wojciechowski C; Knapp RC
    J Reprod Med; 1990 May; 35(5):491-5. PubMed ID: 2191131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian cancer screening.
    Sparks JM; Varner RE
    Obstet Gynecol; 1991 May; 77(5):787-92. PubMed ID: 2014097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses.
    Finkler NJ; Benacerraf B; Lavin PT; Wojciechowski C; Knapp RC
    Obstet Gynecol; 1988 Oct; 72(4):659-64. PubMed ID: 3047614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic importance of the sonographic scoring system in differentiating between malignant and benign ovarian tumors].
    Durdević S
    Med Pregl; 2001; 54(3-4):161-5. PubMed ID: 11759208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer.
    Jacobs I; Oram D; Fairbanks J; Turner J; Frost C; Grudzinskas JG
    Br J Obstet Gynaecol; 1990 Oct; 97(10):922-9. PubMed ID: 2223684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CA 125 in the diagnosis and evaluation of the efficacy of the treatment of cancer of the ovaries].
    Sagan DL; Chebotareva ED; Evtushenko GV
    Med Radiol (Mosk); 1989 Jun; 34(6):39-42. PubMed ID: 2739519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormally high values of CA 125 and CA 19-9 in women with benign tumors.
    Nagata H; Takahashi K; Yamane Y; Yoshino K; Shibukawa T; Kitao M
    Gynecol Obstet Invest; 1989; 28(3):165-8. PubMed ID: 2680806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comprehensive diagnosis of cancer of the ovaries].
    KorsunskiÄ­ VN; Tarasenko IuI; Ostrovskaia EIu; Stupakov IA; Mironova SP
    Med Radiol (Mosk); 1989 Aug; 34(8):51-6. PubMed ID: 2549327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonography of ovarian masses: poor sensitivity of resistive index for identifying malignant lesions.
    Levine D; Feldstein VA; Babcook CJ; Filly RA
    AJR Am J Roentgenol; 1994 Jun; 162(6):1355-9. PubMed ID: 8191998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses.
    Chen DX; Schwartz PE; Li XG; Yang Z
    Obstet Gynecol; 1988 Jul; 72(1):23-7. PubMed ID: 3164105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.